1.13
price up icon13.60%   0.1353
after-market After Hours: 1.12 -0.010 -0.88%
loading
Allarity Therapeutics Inc stock is traded at $1.13, with a volume of 1.17M. It is up +13.60% in the last 24 hours and up +25.56% over the past month. Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$0.9947
Open:
$1.07
24h Volume:
1.17M
Relative Volume:
1.87
Market Cap:
$17.04M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00549
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
+13.00%
1M Performance:
+25.56%
6M Performance:
-14.39%
1Y Performance:
+578.68%
1-Day Range:
Value
$1.06
$1.14
1-Week Range:
Value
$0.945
$1.14
52-Week Range:
Value
$0.1131
$3.95

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name
Name
Allarity Therapeutics Inc
Name
Phone
401-426-4664
Name
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Name
Employee
7
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ALLR's Discussions on Twitter

Compare ALLR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ALLR
Allarity Therapeutics Inc
1.13 15.00M 0 -11.90M -12.75M -206.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Allarity Therapeutics Inc Stock (ALLR) Latest News

pulisher
03:21 AM

Is Allarity Therapeutics Inc. a good long term investmentMassive stock growth - jammulinksnews.com

03:21 AM
pulisher
Jul 22, 2025

Allarity Therapeutics Inc. Stock Analysis and ForecastBreakneck growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Allarity Therapeutics Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Allarity Therapeutics Inc. stock priceStrong return on investment - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

What analysts say about Allarity Therapeutics Inc. stockTremendous return rates - Autocar Professional

Jul 20, 2025
pulisher
Jul 18, 2025

Will Allarity Therapeutics Inc. stock benefit from interest rate changesFree Stock Investment Growth Plan - beatles.ru

Jul 18, 2025
pulisher
Jul 18, 2025

Does Allarity Therapeutics Inc. stock pay reliable dividendsRisk Adjusted Stock Signals - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Allarity Therapeutics Secures New EU Commercial Agreement - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Why Allarity Therapeutics Inc. stock attracts strong analyst attentionTop Rated Trade Entries - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Allarity Therapeutics Inc. stock price move sharplyReal Time Stock Signal - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Allarity Therapeutics Announces New Licensing and - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

Allarity Therapeutics Signs New Precision Oncology Licensing Deal for Breast Cancer | ALLR Stock News - Stock Titan

Jul 15, 2025
pulisher
Jul 13, 2025

Allarity Therapeutics appoints Jeff Ervin as CFO - MSN

Jul 13, 2025
pulisher
Jul 08, 2025

Jeffrey S. Ervin Appointed as Allarity’s New CFO - The Globe and Mail

Jul 08, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics appoints Jeff Ervin as new CFO By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics, Inc. Announces Chief Financial Officer Changes - MarketScreener

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics appoints Jeffrey S. Ervin as part-time chief financial officer - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics appoints Jeff Ervin as new CFO - Investing.com

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics Appoints Jeff Ervin To Succeed Alexander Epshinsky As CFO - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics Appoints Jeff Ervin as New Chief Financial Officer - Nasdaq

Jul 07, 2025
pulisher
Jul 07, 2025

Allarity Therapeutics Announces Appointment of Jeff Ervin as Chief Financial Officer - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

Former NYSE Executive Takes CFO Role at Cancer Drug Developer Allarity Therapeutics - Stock Titan

Jul 07, 2025
pulisher
Jul 02, 2025

Allarity Therapeutics Secures Australian Patent for DRP® Platform - The Globe and Mail

Jul 02, 2025
pulisher
Jun 30, 2025

Allarity Therapeutics Advances Phase 2 Stenoparib Trial - TipRanks

Jun 30, 2025
pulisher
Jun 30, 2025

Allarity Therapeutics receives patent acceptance in Australia for cancer diagnostic - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Allarity Therapeutics Receives Australian Patent Acceptance Notice for Stenoparib DRP® Companion Diagnostic - The Manila Times

Jun 30, 2025
pulisher
Jun 27, 2025

Allarity Therapeutics Doses Second Patient in Phase 2 Ovarian Cancer Trial - MarketScreener

Jun 27, 2025
pulisher
Jun 17, 2025

Allarity Therapeutics Holds Annual Stockholders Meeting - TipRanks

Jun 17, 2025
pulisher
Jun 13, 2025

Allarity Therapeutics Stock Nears Yearly Low: A Trader’s High-Risk Analysis - thekhabrilal

Jun 13, 2025
pulisher
Jun 12, 2025

Allarity Therapeutics, Inc Announces Changes to Board of Directors - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Allarity Therapeutics appoints pharma veteran Høiland to board - Investing.com India

Jun 12, 2025
pulisher
Jun 11, 2025

Allarity Therapeutics Appoints Jesper Høiland to Board - TipRanks

Jun 11, 2025
pulisher
Jun 11, 2025

Allarity Therapeutics appoints pharma veteran Høiland to board By Investing.com - Investing.com Nigeria

Jun 11, 2025

Allarity Therapeutics Inc Stock (ALLR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Cap:     |  Volume (24h):